We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.74%
2 Healthcare 2.42%
3 Financials 2.31%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STCN
13226
DELISTED
Steel Connect, Inc. Common Stock
STCN
$13K ﹤0.01%
1,099
-2,212
-67% -$26.5K
CUEN
13227
DELISTED
Cuentas Inc. Common Stock
CUEN
$13K ﹤0.01%
789
-1,683
-68% -$26K
GROM
13228
PUT
DELISTED
Grom Social Enterprises Inc. Common Stock
GROM
$13K ﹤0.01%
+21
New +$17.5K
TUEM
13229
CALL
DELISTED
Tuesday Morning Corp
TUEM
$13K ﹤0.01%
+380
New +$18.3K
LOGC
13230
CALL
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$13K ﹤0.01%
+18,800
New +$20.6K
NBEV
13231
PUT
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$13K ﹤0.01%
22,800
-10,200
-31% -$7.3K
JP
13232
DELISTED
Jupai Holdings Limited American depositary shares, each representing six ordinary shares
JP
$13K ﹤0.01%
17,606
-33,615
-66% -$24.6K
AIHS icon
13233
Senmiao Technology Ltd
AIHS
$23.9M
$12K ﹤0.01%
+508
New +$15.2K
CHR icon
13234
Cheer Holding
CHR
$3.43M
$12K ﹤0.01%
+7
New +$11.2K
LSTA icon
13235
PUT
Lisata Therapeutics
LSTA
$9.82M
$12K ﹤0.01%
1,093
-534
-33% -$6.11K
NERV icon
13236
Minerva Neurosciences
NERV
$219M
$12K ﹤0.01%
1,842
-4,504
-71% -$27.6K
PLX icon
13237
PUT
Protalix BioTherapeutics
PLX
$179M
$12K ﹤0.01%
10,900
-4,800
-31% -$4.4K
PZG icon
13238
Paramount Gold Nevada
PZG
$132M
$12K ﹤0.01%
19,302
-16,879
-47% -$11.7K
BNKK
13239
Bonk Inc
BNKK
$8.64M
$12K ﹤0.01%
310
-3,888
-93% -$139K
SLDB icon
13240
Solid Biosciences
SLDB
$986M
$12K ﹤0.01%
691
-3,906
-85% -$68.9K
TRX icon
13241
CALL
TRX Gold Corp
TRX
$367M
$12K ﹤0.01%
39,900
-36,600
-48% -$13.5K
QNTM
13242
PUT
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$24.4M
$12K ﹤0.01%
211
-117
-36% -$7.08K
NMTR
13243
PUT
DELISTED
9 Meters Biopharma
NMTR
$12K ﹤0.01%
1,000
-3,355
-77% -$45.8K
NVSAW
13244
DELISTED
New Vista Acquisition Corp. Warrant
NVSAW
$12K ﹤0.01%
31,133
+1,340
+4% +$630
LCI
13245
CALL
DELISTED
Lannett Company, Inc.
LCI
$12K ﹤0.01%
3,650
-23,350
-86% -$103K
LCI
13246
PUT
DELISTED
Lannett Company, Inc.
LCI
$12K ﹤0.01%
+3,875
New +$17K
LFTRW
13247
DELISTED
Lefteris Acquisition Corp. Warrant
LFTRW
$12K ﹤0.01%
46,197
-3,803
-8% -$1.74K
NAVB
13248
CALL
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$12K ﹤0.01%
14,700
+4,000
+37% +$3.67K
CHNR icon
13249
China Natural Resources
CHNR
$5.24M
$11K ﹤0.01%
300
-828
-73% -$29.6K
ASLN
13250
PUT
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$11K ﹤0.01%
300
+10
+3% +$372

Similar funds

Ken Griffin's Q1 2022 Portfolio in Review

As of Q1 2022, Ken Griffin held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Ken Griffin deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Ken Griffin's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Ken Griffin's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Ken Griffin fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Ken Griffin's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Ken Griffin opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Ken Griffin's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.